Patient Scheduling App investor presentation

1. DON’T JUST WIN THE RACE. CHANGE THE GAME.

2. Patient Scheduling App
investment opportunity
If taxi app Uber is worth a staggering $40 BILLION simply by connecting
passengers with drivers, just imagine what an app that connects patients
with doctors would be worth.
PatientSchedulingApp aims to reduce hospital admin costs by at least
10% through the efficient management of patients to doctor pre-operative
appointments. Saving the state of Germany almost £5billion a year.
Designed in partnership with two world class hospitals, mega organisation
Charité in Berlin and cancer specialist The Royal Marsden in London,
PatientSchedulingApp will be the first app to ever successfully undergo
a clinical trial, producing evidence-based research of improved patient
wellbeing and reduced hospital costs.
Built exclusively on Microsoft enabled technologies by Germany’s No1
app development agency, PatientSchedulingApp is designed as a stand
alone mobile application that is sold hardwired onto Windows tablet
devices and sold direct across the world as the first and best scheduling
app to the world’s 300,000 hospitals.
PatientSchedulingApp Ltd is seeking £1m investment for
35% equity in a business that is forecast to be worth £50m
in 5 years.

3. A MOBILE APP TO
SOLVE THE GLOBAL
CRISIS IN HEALTHCARE
KEY BENEFITS OF OUR APP
Problems our app solves:
»» Increasing healthcare costs.
»» Admin and operational
expenditure.
»» Long procurement processes in
fast moving technology.
»» Immediate feedback and
engagement between
pharmaceutical companies,
patients and medical staff.
»» Lengthy waiting times, anxiety,
confusion and exhaustion in
attending pre-op appointments.
»» Effectively manage the flow of patients and
appointments of medical staff.
»» Reduces the pressure on front line staff and
patients alike.
»» Reduces the time spent per patient with each
physician.
»» Increased communication and time
management (emergencies, staff involved,
appointments affected).
»» Providing hospital management with feedback,
analytics and data to better manage resources
and future investment.
»» Establishing an effective marketing platform
that will interact with 60% of a country’s
population, with an average engagement time
of 2 hours.
»» Reduces anxiety and improves patient
wellbeing through effective communication
and information management.
»» Delivering savings that will enable hospitals
to focus more on patient care by improving
patient satisfaction and offering more time
for patients and doctors to interact; therefore
better operational procedures will decrease
mortality and raise quality of life for patients
and hospital employees.
TO VIEW OUR PRODUCT
OVERVIEW Video
https://vimeo.com/117139215

4. UNIQUE SELLING POINTS
DEFENDING OUR MARKET POSITION
»» Savings backed up by evidence-based research from a clinical trial.
»» No patient data stored on application or on databases, anywhere.
»» No capital investment, sold on rolling annual contracts.
»» No IT or costly third party integration or consultancy. Unpack, turn on, save money!
»» Good for hospital cash flow, pay monthly option.
»» 24/7 software support and hardware replaced for new within 48 hours, no questions asked.
»» Annual, free of charge, hardware upgrade.
»» First to market advantage, and once a hospital has a solution they won’t change to another.
»» No app in the world has ever undergone a successful clinical trial.
»» World class partners: Microsoft, Nokia, Intel, The Royal Marsden, The Charité Hospital and
Neofonie App Developers.
»» Microsoft Health Vault.
»» Use of the Charité and Royal Marsden brands, logo, name and reputation across the PR,
publication of the clinical trial results, case studies, social media, sales and marketing
materials and activity.
»» Launch seminar events supported by Microsoft and Intel in partnership with The Charité and
The Royal Marsden planned for launch in Berlin in Nov 2015 and London Jan 2016.
»» Direct route to market by selling to one hospital group managing multiple hospitals.
»» Network independent Data Centric.
»» World class and secure technology platform.
»» Pipeline growth through strategic clients.

5. MARKETING SALES
Three year roll out plan
»» Evidence-based results in the New England
Medical Journal.
»» Feature case study in a half day event for the
healthcare industry, targeting senior hospital
management and stakeholders.
»» Events in London, Germany and Doha (with future
roll out to Paris, Madrid, Rome and others).
»» Each event will be attended by 150 paying
delegates, invited by Microsoft.
»» Highly targeted, profitable sales pitches and
product demonstrations.
»» Glossy report for take-away as our sales brochure.
»» PatientSchedulingApp will appoint a German and
UK health PR company to support the launch and
sales.
»» PatientSchedulingApp has commissioned a
biographer to follow the full journey of the project,
to generate content which will later be used across
all marketing and sales materials and online.
The app will be hardwired at the factory and sold in banks
of x 5 tablet devices (with app). Each tablet will cost €250
or £200 per month. Pre-orders will be taken at the Berlin
and London events. A full time Sales Director will be
recruited for each geographical area.
Year 1 Germany (Austria, Netherlands and Switzerland)
60,000 devices / apps
Year 2 England and Middle East
60,000 devices / apps
Year 3 France
60,000 devices / apps

6. PRODUCT DEVELOPMENT
PHASE1 Development March 2015 / Oct 2015
Due to start upon securing investment:
»» MAR 2015 Software development
starts.
»» MAY 2015 Clinical trial on software
starts.
»» JUL 2015 Clinical trial ends.
»» AUG 2015 Results from clinical trial
written up.
»» OCT 2015 Results from clinical trial
are published.
»» NOV 2015 Recruitment of Sales
Director and UK support team.
»» NOV 2015 Product launch seminar
in Berlin.
Completed:
»» Appoint Berlin based English speaking Project Director.
»» Appoint German IT / IP specialist law firm.
»» Appoint Berlin based development agency.
»» Sign contracts with Charité, The Royal Marsden and
Microsoft Germany.
»» Retain the services of a senior medical professional to
oversee the product development.
»» Ethical commission and data protection vote.
»» Hold first full team project kick off meeting with all
stakeholders.
»» Prepare full investor presentation for funding to
develop and launch product.
PHASE2 Sales November 2015 / May 2017
»» Focus on selling across Europe .
PHASE 3 Self-funded Global Expansion September 2017
»» Scale and deliver to large, high value clients.
»» Secure strategic partnerships and market share in BRIC countries and North America.
»» Stock market listing.

7. FINANCES
Sales / profit targets
»» The PatientSchedulingApp will cost €500,000 to develop.
»» Annual overheads total €250,000.
»» Annual support costs total €150,000.
»» Annual marketing budget set at 15% of sales revenue
(€100,000 in year one).
»» The app will be sold, pre-loaded on Nokia1310 in banks of five.
»» The average large hospital will require 20 tablets (a hospital the
size of the Charité will require 50 tablets).
»» Direct costs for each Nokia1310 are €300.
2015 £40,000 / (£162,283)
2016 £1,712,000 / £597,053
2017 £8,384,000 / £6,669,710
Andrew Grant
Chief Executive Officer
andrew.grant@appadventure.co.ukDON’T JUST WIN THE RACE. CHANGE THE GAME.